Analyze Diet

[Recombinant antibodies: a new application in scorpion envenomation?].

Abstract: Serotherapy is the only specific treatment for envenomation. The antibodies are obtained after the purification of serum from hyperimmunised horses and are used after fragmentation in the form of polyclonal Fab or F(ab)'2. The anti-venom sera are heterogeneous, and their protective effect is often weak. The administration of these preparations induces risks of immediate or delayed side effects: hypersensitivity reactions, anaphylactic shock and serum sickness. This observation led us to develop new forms of antibodies produced by molecular engineering, capable of specifically neutralizing the neurotoxins responsible for the toxicity of the venom of Androctonus australis Hector. The recombinant antibody fragments are more homogeneous than conventional antivenoms and perfectly characterized in terms of specific activity. The method used to obtain them eliminates the risk of transmission by non-conventional transmissible agents. The earliest results confirm the importance of these new molecules (scFv recombinant Fab, diabody, triabody) and their ability to neutralize the action of scorpion neurotoxins. They could open the path to a new generation of more homogeneous antivenoms that are better tolerated and have well-characterized intrinsic properties.
Publication Date: 2006-01-24 PubMed ID: 16425719
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • English Abstract
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article explores the potential application of recombinant antibodies as a more effective and better-tolerated treatment for scorpion envenomation than current serotherapy methods.

Current Methods and Limitations

  • The established treatment for envenomation, or the harmful effects caused by a high concentration of toxins in the body like a venomous sting or bite, is serotherapy – the administration of purified antibodies derived from the serum of hyperimmunised horses.
  • These antibodies are used after fragmentation into polyclonal Fab or F(ab)’2 forms.
  • However, anti-venom sera are heterogeneous and can have a limited protective effect.
  • The current approach can lead to serious side effects, including immediate or delayed hypersensitivity reactions, anaphylactic shock, and serum sickness – a reaction to certain antitoxin injections.

Recombinant Antibodies: A Potential Solution

  • In view of these limitations, the researchers are investigating the development of new forms of antibodies using molecular engineering specifically to neutralize the neurotoxins responsible for the toxicity of Androctonus australis Hector scorpion venom.
  • These recombinant antibody fragments differ from conventional antivenoms in that they are more homogeneous and their specific activities are perfectly characterized, meaning their expected action can be more accurately predicted.
  • Moreover, the method of deriving these antibodies also eliminates the risk of non-conventional transmissible agent transmission, which further increases their safety profile.

Preliminary Results and Future Prospects

  • Initial results from the study clearly highlight the importance and potential of these new forms of antibodies (scFv recombinant Fab, diabody, triabody) through their demonstrated ability to neutralize scorpion neurotoxins.
  • Their use could potentially pave the way for a new generation of antivenoms that are more homogeneous, better-tolerated by patients, and have well-characterized intrinsic properties, thus substantially improving the management and treatment of scorpion envenomation.

Cite This Article

APA
Muzard J, Billiald P, Goyffon M, Aubrey N. (2006). [Recombinant antibodies: a new application in scorpion envenomation?]. Bull Soc Pathol Exot, 98(5), 383-385.

Publication

ISSN: 0037-9085
NlmUniqueID: 9212564
Country: France
Language: fre
Volume: 98
Issue: 5
Pages: 383-385

Researcher Affiliations

Muzard, J
  • USM 505, CP 39, Muséum national d'histoire naturelle, 12, rue Buffon, 75231 Paris 05, France.
Billiald, P
    Goyffon, M
      Aubrey, N

        MeSH Terms

        • Animals
        • Antibodies, Monoclonal / immunology
        • Antibodies, Monoclonal / therapeutic use
        • Antibody Specificity / immunology
        • Humans
        • Immunization, Passive
        • Immunoglobulin Fab Fragments / immunology
        • Immunoglobulin Fragments / immunology
        • Neurotoxins / antagonists & inhibitors
        • Neurotoxins / immunology
        • Protein Engineering
        • Recombinant Proteins
        • Scorpion Stings / therapy
        • Scorpion Venoms / antagonists & inhibitors
        • Scorpion Venoms / immunology
        • Scorpions

        Citations

        This article has been cited 0 times.